STOCK TITAN

AIP Insider Sells 30,538 Shares; 6,421 RSUs to Trade on 10/07/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arteris, Inc. filing a Form 144 notifies a proposed sale of 6,421 common shares (acquired as restricted stock units) with an aggregate market value of $87,197.18, through Morgan Stanley Smith Barney LLC on or about 10/07/2025. The RSUs were recorded as acquired on 10/01/2025 and the filing lists previous sales by the same person totaling 30,538 shares during the prior three months, generating gross proceeds of $336,546.61. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 sales plans used for several prior transactions.

Positive

  • Transaction transparency: Filing discloses the proposed sale amount and broker (Morgan Stanley Smith Barney LLC)
  • Source of shares clear: Shares to be sold were acquired as Restricted Stock Units on 10/01/2025

Negative

  • Significant insider selling: 30,538 shares sold in prior three months for gross proceeds of $336,546.61
  • Additional near-term sale: Proposed sale of 6,421 shares on or about 10/07/2025, increasing insider supply

Insights

TL;DR: Insider proposes sale of RSUs and has executed material sales recently.

The filing shows a proposed sale of 6,421 shares acquired as restricted stock units on 10/01/2025

Prior sales by the same person total 30,538 shares for gross proceeds of $336,546.61 over the past three months, with multiple trades executed under 10b5-1 plans. The immediate dependency is the timing noted as "approximate date of sale" 10/07/2025, and execution will occur via Morgan Stanley Smith Barney LLC.

Watch for the actual execution on 10/07/2025 and any subsequent amendment disclosing a different sale amount or cancellation; continued selling at this scale relative to outstanding shares could be meaningful to supply, though no financial performance metrics are provided here.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Arteris (AIP) Form 144 report?

The Form 144 reports a proposed sale of 6,421 common shares (RSUs) valued at $87,197.18, with an approximate sale date of 10/07/2025.

Who will execute the sale on Form 144 for AIP?

The filing lists Morgan Stanley Smith Barney LLC as the broker handling the proposed sale.

Were there recent insider sales by the same person at Arteris (AIP)?

Yes. The filing shows the person sold a total of 30,538 shares in the prior three months, receiving gross proceeds of $336,546.61.

What is the acquisition method for the shares being sold?

The shares were acquired as Restricted Stock Units on 10/01/2025.

Does the filer assert any undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

718.16M
31.36M
30.11%
47.91%
3.85%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL